At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
trans-cutaneous auricular sensory stimulationdevice
Likely dose
Transcutaneous auricular sensory stimulation (device-based intervention; specific stimulation parameters not detailed)AI-extracted
Key inclusion· 2
- ✓Acute ischemic stroke requiring mechanical thrombectomy (under general anesthesia or sedation)
- ✓Hypertension on admission: systolic BP >140 mmHg and/or diastolic BP >80 mmHg
Key exclusion· 4
- ✕Concurrent participation in another clinical trial with a similar biological mechanism
- ✕Prior enrollment in the VANS trial
- ✕Anatomical or other contraindication to transcutaneous auricular sensory stimulation
- ✕Pregnancy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vagal Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke Requiring Mechanical Thrombectomy.
In Brief
A clinical study evaluating trans-cutaneous auricular sensory stimulation for Ischemic Stroke and 3 related conditions. Completed, enrolled 36 participants across 1 site.
Detailed Summary
Autonomic modulation by transcutaneous vagal nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: a phase IIa, sham controlled randomised trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartApr 2023
Primary CompletionJul 2023
TodayJul 2026
First PostedJun 14, 2022
Enrollment StartApr 26, 2023
Primary CompletionJul 21, 2023
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.0 years ago
Interventions
trans-cutaneous auricular sensory stimulationdevice
Transcutaneous auricular sensory stimulation